Capsugel: latest news - GoINPHARMA
Wednesday, 19 September 2018 - 12:11


Lonza to acquire Capsugel for $5.5bn

Lonza Group AG acquired US-based Capsugel S.A. from KKR fund for $5.5bn in cash, including debt ($2bn), corresponding to a 15.1x EBITDA multiple. The Basel, Switzerland-based group stated it expects to achieve operating synergies of approximately CHF30m pa, as well…

Lonza close to deal to acquire Capsugel

Switzerland-based group Lonza is now close to acquire Capsugel, the same Lonza confirmed today in a brief press release, adding it has a strong interest in the US-based (New Jersey) company, owned by private-equity KKR & Co. According to experts,…